Guangzhou Improve Med Instrument - Asset Resilience Ratio

Latest as of March 2026: 4.20%

Guangzhou Improve Med Instrument (300030) has an Asset Resilience Ratio of 4.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥43.00 Million
≈ $6.29 Million USD Cash + Short-term Investments

Total Assets

CN¥1.02 Billion
≈ $149.71 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Guangzhou Improve Med Instrument's Asset Resilience Ratio has changed over time. Check 300030 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Improve Med Instrument's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Improve Med Instrument stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥43.00 Million 4.2%
Total Liquid Assets CN¥43.00 Million 4.20%

Asset Resilience Insights

  • Limited Liquidity: Guangzhou Improve Med Instrument maintains only 4.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou Improve Med Instrument Industry Peers by Asset Resilience Ratio

Compare Guangzhou Improve Med Instrument's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hangzhou Alltest Biotech Co. Ltd. A
SHG:688606
Medical Instruments & Supplies 11.88%
Daxor Corporation
NASDAQ:DXR
Medical Instruments & Supplies 65.10%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%

Annual Asset Resilience Ratio for Guangzhou Improve Med Instrument (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Improve Med Instrument.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 1.61% CN¥23.00 Million
≈ $3.37 Million
CN¥1.43 Billion
≈ $208.66 Million
+1.42pp
2022-12-31 0.19% CN¥3.00 Million
≈ $438.99K
CN¥1.56 Billion
≈ $228.01 Million
-2.91pp
2020-12-31 3.10% CN¥54.07 Million
≈ $7.91 Million
CN¥1.74 Billion
≈ $255.31 Million
-0.42pp
2019-12-31 3.52% CN¥53.00 Million
≈ $7.76 Million
CN¥1.51 Billion
≈ $220.49 Million
+3.06pp
2018-12-31 0.45% CN¥6.86 Million
≈ $1.00 Million
CN¥1.51 Billion
≈ $221.13 Million
+0.08pp
2017-12-31 0.37% CN¥6.53 Million
≈ $956.16K
CN¥1.75 Billion
≈ $255.48 Million
--
2016-12-31 0.00% CN¥0.00
≈ $0.00
CN¥1.47 Billion
≈ $215.09 Million
--
2014-12-31 0.38% CN¥3.90 Million
≈ $570.69K
CN¥1.02 Billion
≈ $149.16 Million
--
pp = percentage points

About Guangzhou Improve Med Instrument

SHE:300030 China Medical Instruments & Supplies
Market Cap
$294.08 Million
CN¥2.01 Billion CNY
Market Cap Rank
#14866 Global
#4395 in China
Share Price
CN¥6.50
Change (1 day)
+2.36%
52-Week Range
CN¥5.80 - CN¥9.29
All Time High
CN¥22.76
About

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more